10/23/2014 TGV-THERAPEUTICS HONORED TO ATTEND PRIX GALIEN AWARD CEREMONY

New York, NY, October 23, 2014. TGV-Therapeutics announces that it was selected by the Prix Galien Jury as the most exciting and promising project. As the selected laureate, representatives from TGV-Therapeutics have taken part of the Prix Galien award ceremony on October 23rd. The Prix Galien recognizes the important research necessary to develop innovative medicines and devices that have a lifesaving impact on individuals and families across the globe. The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. The Foundation oversees and directs activities worldwide for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. The Prix Galien was created in 1970 in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.